58S-17837-13224
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 032 / NH
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-04-29
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-07-29
-
2021-10-28
Survey response — 6 months, dose 2MedDRA: Chills, Cough, Fatigue, Headache — Feeling: Good · Be unable to work or attend schoolFree text: Approximately two weeks ago I experienced some very mild COVID-like symptoms for approximately three days. Unexplained cough with no production or congestion, mild chills with no elevated or subnormal temperature, and fatigue with headache.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Survey response — 12 months, dose 2MedDRA: Fatigue, Parosmia, Pre-existing disease, Weight increased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Covid-19 infection December 2020, recovered, and since have had trouble with fatigue, weight gain, and parosmia (smells not registering right). Things are getting better, but very slowly.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech |
Free text
Release 10 — 6 months, dose 2
Symptoms: Approximately two weeks ago I experienced some very mild COVID-like symptoms for approximately three days. Unexplained cough with no production or congestion, mild chills with no elevated or subnormal temperature, and fatigue with headache.
Release 11 — 12 months, dose 2
Symptoms: Covid-19 infection December 2020, recovered, and since have had trouble with fatigue, weight gain, and parosmia (smells not registering right). Things are getting better, but very slowly.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Weight increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release